 |
|
|
| |
Efficacy and safety of combination treatment with siRNA JNJ-73763989 and capsid assembly modulator JNJ-56136379 (bersacapavir) in HBeAg negative virologically suppressed chronic hepatitis B patients: Follow-up week 48 end of study results from REEF-2
|
| |
| |
AASLD 2022 Nov 4-8
Kosh Agarwal,1 Maria Buti,2 Florian van Bommel,3 Pietro Lampertico,4,5 Ewa Janczewska,6 Marc Bourliere,7 Thomas Vanwolleghem,8,9 Oliver Lenz,10 Thierry Verbinnen,10 Thomas N. Kakuda,11 Cristiana Mayer,12 John Jezorwski,12 Daniel Muenz,13 Maria Beumont,10
Ronald Kalmeijer,12 Michael Biermer,10 Isabelle Lonjon-Domanec10
|
| |
|
|
|
|
|
